Cystoisosporiasis in Immunocompetent and Immunocompromised Patients, But Neglected in SARS-COV-2/COVID-19 Patients?

Author Details

Dr. Chrysanthus Chukwuma Sr

Journal Details

Published

Published: 9 December 2020 | Article Type :

Abstract

Cystoisosporiasis (formerly isosporiasis) is caused by Cystoisospora belli (erstwhile named Isospora belli) is encountered globally, particularly in tropical and subtropical regions. Cystoisosporiasis is a human intestinal disease whose etiology is the parasite Cystoisospora belli with infection frequent in immunocompromised subjects, principally HIV-infected and AIDS patients. This coccidium parasite infects the epithelial cells and lining of the villi of the small and large intestines. C. belli is the least frequent of the three intestinal coccidia, viz: Cryptosporidium, microsporidium and C. belli which perturb humans. The clinical presentation of cystoisosporiasis gives a semblance of inflammatory bowel disease and irritable bowel syndrome, as well as other gastrointestinal symptoms, nausea, vomiting and diarhoea found in COVID-19, AIDS and HIV-infected patients. Research has not presented comorbid features of COVID-19 and cystoisosporiasis. The oocytes of C. belli are visualizable microscopically on wet mounts via brightfield, differential interference contrast (DIC) and epifluorescence. Trimethoprin sulfamethoxazole constitute the normal treatment of choice.

Keywords: Cystoisosporabelli, HIV, AIDS, inflammatory bowel syndrome, diarrhoea

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright © Author(s) retain the copyright of this article.

Statistics

361 Views

481 Downloads

Volume & Issue

Article Type

How to Cite

Citation:

Dr. Chrysanthus Chukwuma Sr. (2020-12-09). "Cystoisosporiasis in Immunocompetent and Immunocompromised Patients, But Neglected in SARS-COV-2/COVID-19 Patients?." *Volume 3*, 4, 10-13